Fc epsilon RI alpha

Fc epsilon RI alpha

Fc epsilon RI alpha 詳細

Molecule Name
IgE Fc receptor, alpha-subunit
分子の別称
FCER1A,FCE1A,FcERI
Drug Development Progress
治験薬の数1
市販薬剤の数1
研究&開発段階Approved
ターゲットの別称
Fc Fragment Of IgE, High Affinity I, Receptor For; Alpha Polypeptide,FCE1A,IgE Fc receptor subunit alpha,Fc-epsilon RI-alpha,FCER1A,Fc Fragment Of IgE Receptor Ia,Fc Fragment Of IgE, High Affinity I, Receptor For,Alpha Polypeptide,Fc Epsilon Receptor Ia,FcERI,Immunoglobulin E Receptor, High-Affinity, Of Mast Cells, Alpha Polypeptide,High Affinity Immunoglobulin Epsilon Receptor Alpha-Subunit,High Affinity Immunoglobulin Epsilon Receptor Subunit Alpha,Fc IgE Receptor, Alpha Polypeptide,Fc Epsilon RI Alpha-Chain,FCER1
バックグランド
Fc epsilon RI alpha (FcεRIα) is the α-chain of the high-affinity IgE receptor (FcεRI), a critical mediator of type I hypersensitivity. As a transmembrane glycoprotein in the immunoglobulin superfamily, its extracellular domain specifically binds the Fc region of IgE. Mainly expressed on mast cells and basophils, FcεRIα cross-linking (by IgE-allergen complexes) triggers cell degranulation, releasing histamine and proinflammatory mediators—driving allergies, asthma, and anaphylaxis. It also participates in immune surveillance. Owing to its central role in allergic responses, FcεRIα is a key therapeutic target for anti-allergy agents.

Fc epsilon RI alpha 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
LesigerceptYH-35324; GI-301Phase 2 ClinicalYuhan Corp
Chronic Urticaria; Hypersensitivity; Immune System Diseases; Urinary Tract Infections; Urticaria
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Benzylpenicilloyl PolylysineApprovedAllerquest LlcPre-penUnited StatesAnaphylaxis; Diagnostic agentsAllerquest Inc1974-07-25
Anaphylaxis; Diagnostic agents
詳細